The largest database of trusted experimental protocols

Ch223191

Manufactured by Apexbio

CH223191 is a laboratory equipment product. It is designed to perform core functions for scientific research and analysis. The detailed specifications and intended uses are not available.

Automatically generated - may contain errors

2 protocols using ch223191

1

Pituitary Explant Culture with MEHP/DEHP

Check if the same lab product or an alternative is used in the 5 most similar protocols
Embryos from CD-1 mice were taken out of the uterus on embryonic day 16.5 and tissue from each embryo was collected for SRY genotyping for sex determination. The whole pituitary glands were taken out and transferred to 96-well plate with 50μL phosphate buffered saline (PBS) +1% antibiotic/antimycotic solution (anti-anti, Thermo-Fisher). Pituitaries were washed twice with PBS +1% anti-anti and 50 μL of media (phenol red-free DMEM/F12 (Thermo-Fisher), supplemented with 10% charcoal-stripped fetal bovine serum (Sigma-Aldrich) and 1% anti-anti) with different treatments (0.1 μg/mL, 1 μg/mL, 10 μg/mL and 100 μg/mL MEHP/DEHP (Sigma) added to each well. The concentrations of MEHP/DEHP were picked based on previous papers describing mouse ovarian cultures with MEHP/DEHP [30 (link),31 (link)]. Pituitaries were cultured at 37 °C for 72 hours without changing the media. To co-treat the pituitary with MEHP and AhR antagonist- CH223191 (ApexBio), pituitaries were harvested and washed as described above and first treated with the antagonist dissolved in DMSO in the 37 °C incubator for 2 hours, then MEHP was added at the final concentration of 100 μg/mL. Some pituitaries were only treated with the antagonist to eliminate possible effects of the antagonist. The final concentration of the AhR antagonist was at 1μM as instructed by the manufacturer’s product catalog.
+ Open protocol
+ Expand
2

Modulation of Gut-Brain Axis in Parkinson's

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rats were randomly divided into six groups (n = 6 rats/group): Normal saline‐treated group (Control, CTRL), rotenone + Trp‐deficient‐treated group (Rot+Trpdef), rotenone + Trp‐treated group (Rot+Trp), rotenone + Trp + ampicillin‐treated group (Rot+Trp+Amp), rotenone + Trp + vancomycin‐treated group (Rot+Trp+Van), and rotenone + Trp + CH223191‐treated group (Rot+Trp+AhRi).
The rats in the CTRL group were treated daily with 0.1 ml saline for 4 weeks by subcutaneous injection through the neck and fed with normal diet. The rats in the other groups were subcutaneously injected with rotenone at a concentration of 2 mg/kg in the neck. The rats in Rot+Trpdef group were fed with Trp‐deficient forage. The left four groups were fed with Trp‐rich forage. Treatments with 300 mg/kg ampicillin or 150 mg/kg vancomycin by oral administration were performed at week four after the injection of rotenone. The rats in Rot+Trp+AhRi group were treated with 10 mg/kg CH223191 (cat no. A8609; APeXBIO Technology LLC) by oral administration at the week 1 after rotenone injection.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!